COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > A Big Thank you to Proph

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jul 05, 2024 12:45pm

46 Views

Post# 36119942

RE:RE:RE:A Big Thank you to Proph

Could AEZS use its oat beta glucan chewy with its avenanthramide pill as a one-two punch against cholesterol and inflammation linked to heart disease? Arterial plaques also get inflammed by COVID infection and result in heart attacks.

@COVID19_disease

Oct 24, 2023

COVID Coronary Plaque Infection Confirms CV Risk New evidence shows for the first time that the virus that causes COVID directly infects atherosclerotic plaques in the coronary arteries, producing a persistent inflammatory response.

<< Previous

Bullboard Posts

Next >>

How to navigate the ups and downs of investing in AI